Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: Results from the SEIFEM 2010-B registry

Clinical Infectious Diseases

Volumn 55, Issue 11, 2012, Pages 1515-1521

  Pagano, Livio ^a   Caira, Morena ^a   Candoni, Anna ^b   Aversa, Franco ^c   Castagnola, Carlo ^d   Caramatti, Cecilia ^e   Cattaneo, Chiara ^f   Delia, Mario ^f   De Paolis, Maria Rosaria ^g   Di Blasi, Roberta ^a   Di Caprio, Luigi ^h   Fanci, Rosa ⁱ   Garzia, Mariagrazia ^j   Martino, Bruno ^k   Melillo, Lorella ^e   Mitra, Maria Enza ^e   Nadali, Gianpaolo ^l   Nosari, Annamaria ^m   Picardi, Marco ⁿ   Potenza, Leonardo ^o   Salutari, Prassede ^p   Trecarichi, Enrico Maria ^a   Tumbarello, Mario ^a   Verga, Luisa ^q   Vianelli, Nicola ^r   Busca, Alessandro ^s   more..

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e UNIVERSITY OF PARMA   (Italy)

^f UNIVERSITY OF BARI   (Italy)

^g Dipartimento di Ematologia   (Italy)

^h UNIVERSITY OF ROME TOR VERGATA   (Italy)

ⁱ UNIVERSITY OF FLORENCE   (Italy)

^j SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^k BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^l FATEBENEFRATELLI HOSPITAL   (Italy)

^m OSPEDALE NIGUARDA CA GRANDA   (Italy)

ⁿ UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^o UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^p SPIRITO SANTO HOSPITAL   (Italy)

^q UNIVERSITY OF MILAN   (Italy)

^r UNIVERSITY OF BOLOGNA   (Italy)

^s MOLINETTE HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; POSACONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; ITALY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOSIS; OVERALL SURVIVAL; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER;

AGED; ANTIFUNGAL AGENTS; FEMALE; HUMANS; ITRACONAZOLE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MYCOSES; TRIAZOLES;

EID: 84869049025     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis773     Document Type: Article

References (31)

1. Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006; 91:1068-75.
2. Pagano L, Caira M, Nosari A, et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study-Sorveglianza Epidemiologica Infezioni Fungine nelle Emopatie Maligne. Clin Infect Dis 2007; 45:1161-70.
3. Neofytos D, Horn D, Anaissie E, et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 2009; 48:265-73.
4. Pagano L, Caira M, Rossi G, et al. A prospective survey of febrile events in hematological malignancies. Ann Hematol 2011; 91:767-74.
5. Caira M, Girmenia C, Fadda RM, et al. Invasive fungal infections in patients with acute myeloid leukemia and in those submitted to allogeneic hemopoietic stem cell transplant: who is at highest risk? Eur J Haematol 2008; 81:242-3.
6. Pagano L, Caira M, Picardi M, et al. Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality-SEIFEM-C report. Clin Infect Dis 2007; 44:1524-5.
7. Pagano L, Caira M, Nosari A, et al. Etiology of febrile episodes in patients with acute myeloid leukemia: results from the Hema e-Chart Registry. Arch Intern Med 2011; 171:1502-3.
8. Pagano L, Caira M, Candoni A, et al. Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. Haematologica 2010; 95:644-50.
9. Glasmacher A, Prentice A, Gorschluter M, Engelhart S, Hahn C, Djulbegovic B. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3597 patients. J Clin Oncol 2003; 21:4615-26.
10. Robenshtok E, Gafter-Gvili A, Goldberg E, Leibovici L, Paul M. Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis. J Clin Oncol 2007; 25:5471-89.
11. Cornely OA, Maertens J, Winston DJ, et al. Posaconazole vs fluconazole or itraconazole prophylaxis in patients with neutropenia. New Engl J Med 2007; 356:348-59.
12. Ullmann AJ, Lipton JH, Vesole DH, et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. New Engl J Med 2007; 356:335-47.
13. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46:327-60.
14. Maertens J, Marchetti O, Herbrecht R, et al. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3-2009 update. Bone Marrow Transplant 2011; 46:709-18.
15. Cornely OA, Böhme A, Buchheidt D, et al. Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Haematol 2009; 94:113-22.
16. Egerer G, Geist MJ. Posaconazole prophylaxis in patients with acute myelogenous leukaemia-results from an observational study. Mycoses 2011; 54(suppl 1):7-11.
17. Hahn J, Stifel F, Reichle A, Holler E, Andreesen R. Clinical experience with posaconazole prophylaxis-a retrospective analysis in a haematological unit. Mycoses 2011; 54(suppl 1):12-6.
18. Michallet M, Sobh M, Morisset S, et al. Risk factors for invasive aspergillosis in acute myeloid leukemia patients prophylactically treated with posaconazole. Med Mycol 2011; 49:681-7.
19. Vehreschild JJ, Rüping MJ, Wisplinghoff H, et al. Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia: a 6 year experience of the Cologne AML cohort. J Antimicrob Chemother 2010; 65:1466-71.
20. Ananda-Rajah MR, Grigg A, Downey MT, et al. Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/ itraconazole in patients with acute myeloid leukaemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period. Haematol 2011; 97:459-63.
21. Girmenia C, Frustaci AM, Gentile G, et al. Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a singlecenter, real-life experience. Haematologica 2012; 97:560-7.
22. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46:1813-21.
23. Maertens J, Theunissen K, Verhoef G, et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 2005; 41:1242-50.
24. Wingard JR, Ribaud P, Schlamm HT, Herbrecht R. Changes in causes of death over time after treatment for invasive aspergillosis. Cancer 2008; 112:2309-12.
25. Rogers TR, Slavin MA, Donnelly JP. Antifungal prophylaxis during treatment for haematological malignancies: are we there yet? Br J Haematol 2011; 153:681-97.
26. Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 2005; 40:1762-9.
27. McCulloch E, Ramage G, Rajendran R, et al. Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis. J Clin Pathol 2012; 65:83-6.
28. Hoenigl M, Salzer HJ, Raggam RB, et al. Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies. Med Mycol 2011; 39:510-3.
29. Lerolle N, Lafaurie M, Touratier S, et al. Breakthrough invasive fungal infections in patients with hematological cancers receiving posaconazole prophylaxis: a four-year study. Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, September 2011. Abstract M-1521.
30. Even C, Bastuji-Garin S, Hicheri Y, et al. Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study. Haematologica 2011; 96:337-41.
31. Michallet M, Bénet T, Sobh M, et al. Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients. Eur J Clin Microbiol Infect Dis 2011; 31:991-7.